O	O	O	0	10	Regulation	Regulation	B-NP	NN	O	0	ROOT	O
O	O	O	11	13	of	of	B-PP	IN	O	1	NMOD	O
O	O	O	14	18	gene	gene	B-NP	NN	O	4	NMOD	O
O	O	O	19	29	expression	expression	I-NP	NN	O	2	PMOD	O
O	O	O	30	34	with	with	B-PP	IN	O	4	NMOD	O
T4	B-Entity	B-Entity	35	41	double	double	B-NP	JJ	O	10	NMOD	O
T4	I-Entity	I-Entity	41	42	-	-	I-NP	HYPH	O	10	P	O
T4	I-Entity	I-Entity	42	50	stranded	stranded	I-NP	JJ	O	10	NMOD	O
T4	I-Entity	I-Entity	51	67	phosphorothioate	phosphorothioate	I-NP	NN	O	10	NMOD	O
T4	I-Entity	I-Entity	68	84	oligonucleotides	oligonucleotide	I-NP	NNS	O	5	PMOD	O
O	O	O	84	85	.	.	O	.	O	1	P	O

O	O	O	87	97	Alteration	Alteration	B-NP	NN	O	12	SUB	O
O	O	O	98	100	of	of	B-PP	IN	O	1	NMOD	O
O	O	O	101	105	gene	gene	B-NP	NN	O	4	NMOD	O
O	O	O	106	119	transcription	transcription	I-NP	NN	O	2	PMOD	O
O	O	O	120	122	by	by	B-PP	IN	O	1	NMOD	O
O	O	O	123	133	inhibition	inhibition	B-NP	NN	O	5	PMOD	O
O	O	O	134	136	of	of	B-PP	IN	O	6	NMOD	O
O	O	O	137	145	specific	specific	B-NP	JJ	O	11	NMOD	O
O	O	O	146	161	transcriptional	transcriptional	I-NP	JJ	B-protein	11	NMOD	B-protein
O	O	O	162	172	regulatory	regulatory	I-NP	JJ	I-protein	11	NMOD	I-protein
O	O	O	173	181	proteins	protein	I-NP	NNS	I-protein	7	PMOD	I-protein
O	O	O	182	184	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	185	194	necessary	necessary	B-ADJP	JJ	O	12	PRD	O
O	O	O	195	198	for	for	B-PP	IN	O	13	AMOD	O
O	O	O	199	210	determining	determine	B-VP	VBG	O	14	PMOD	O
O	O	O	211	214	how	how	B-ADVP	WRB	O	15	VMOD	O
O	O	O	215	220	these	these	B-NP	DT	O	18	NMOD	O
O	O	O	221	228	factors	factor	I-NP	NNS	O	19	SUB	O
O	O	O	229	240	participate	participate	B-VP	VBP	O	16	SBAR	O
O	O	O	241	243	in	in	B-PP	IN	O	19	VMOD	O
O	O	O	244	252	cellular	cellular	B-NP	JJ	O	22	NMOD	O
O	O	O	253	268	differentiation	differentiation	I-NP	NN	O	20	PMOD	O
O	O	O	268	269	.	.	O	.	O	12	P	O

O	O	O	270	273	The	The	B-NP	DT	O	2	NMOD	O
O	O	O	274	283	functions	function	I-NP	NNS	O	6	SUB	O
O	O	O	284	286	of	of	B-PP	IN	O	2	NMOD	O
O	O	O	287	292	these	these	B-NP	DT	O	5	NMOD	O
O	O	O	293	301	proteins	protein	I-NP	NNS	O	3	PMOD	O
O	O	O	302	305	can	can	B-VP	MD	O	0	ROOT	O
O	O	O	306	308	be	be	I-VP	VB	O	6	VC	O
O	O	O	309	320	antagonized	antagonize	I-VP	VBN	O	7	VC	O
O	O	O	321	323	by	by	B-PP	IN	O	8	VMOD	O
O	O	O	324	331	several	several	B-NP	JJ	O	11	NMOD	O
O	O	O	332	339	methods	method	I-NP	NNS	O	13	NMOD	O
O	O	O	339	340	,	,	O	,	O	13	P	O
O	O	O	341	345	each	each	B-NP	DT	O	9	PMOD	O
O	O	O	346	350	with	with	B-PP	IN	O	13	NMOD	O
O	O	O	351	359	specific	specific	B-NP	JJ	O	16	NMOD	O
O	O	O	360	371	limitations	limitation	I-NP	NNS	O	14	PMOD	O
O	O	O	371	372	.	.	O	.	O	6	P	O

O	O	O	373	383	Inhibition	Inhibition	B-NP	NN	O	10	SUB	O
O	O	O	384	386	of	of	B-PP	IN	O	1	NMOD	O
O	O	O	387	395	sequence	sequence	B-NP	NN	O	9	NMOD	O
O	O	O	395	396	-	-	O	HYPH	O	9	NMOD	O
O	O	O	396	404	specific	specific	B-NP	JJ	O	9	NMOD	O
T5	B-Entity	B-Entity	405	408	DNA	DNA	I-NP	NN	B-protein	9	NMOD	B-protein
O	O	O	408	409	-	-	B-VP	HYPH	I-protein	9	NMOD	I-protein
O	O	O	409	416	binding	bind	B-NP	VBG	I-protein	9	NMOD	I-protein
O	O	O	417	425	proteins	protein	I-NP	NNS	I-protein	2	PMOD	I-protein
O	O	O	426	429	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	430	438	achieved	achieve	I-VP	VBN	O	10	VC	O
O	O	O	439	443	with	with	B-PP	IN	O	11	VMOD	O
T6	B-Entity	B-Entity	444	450	double	double	B-NP	JJ	O	20	NMOD	O
T6	I-Entity	I-Entity	450	451	-	-	I-NP	HYPH	O	20	P	O
T6	I-Entity	I-Entity	451	459	stranded	stranded	I-NP	JJ	O	20	NMOD	O
T6	I-Entity	I-Entity	460	461	(	(	O	(	O	18	DEP	O
T6	I-Entity	I-Entity	461	463	ds	d	B-NP	NNS	O	18	DEP	O
T6	I-Entity	I-Entity	463	464	)	)	O	)	O	15	AMOD	O
T6	I-Entity	I-Entity	465	481	phosphorothioate	phosphorothioate	B-NP	NN	O	20	NMOD	O
T6	I-Entity	I-Entity	482	498	oligonucleotides	oligonucleotide	I-NP	NNS	O	12	PMOD	O
O	O	O	499	503	that	that	B-NP	WDT	O	20	NMOD	O
O	O	O	504	513	contained	contain	B-VP	VBD	O	21	SBAR	O
O	O	O	514	521	octamer	octamer	B-NP	NN	B-DNA	28	NMOD	B-DNA
O	O	O	522	524	or	or	I-NP	CC	I-DNA	28	NMOD	I-DNA
O	O	O	525	530	kappa	kappa	I-NP	NN	I-DNA	28	NMOD	I-DNA
O	O	O	531	532	B	B	I-NP	NN	I-DNA	28	NMOD	I-DNA
T7	B-Entity	B-Entity	533	542	consensus	consensus	I-NP	NN	I-DNA	28	NMOD	I-DNA
T7	I-Entity	I-Entity	543	552	sequences	sequence	I-NP	NNS	I-DNA	22	OBJ	I-DNA
O	O	O	552	553	.	.	O	.	O	10	P	O

O	O	O	554	557	The	The	B-NP	DT	O	3	NMOD	O
T8	B-Entity	B-Entity	558	574	phosphorothioate	phosphorothioate	I-NP	NN	O	3	NMOD	O
T8	I-Entity	I-Entity	575	591	oligonucleotides	oligonucleotide	I-NP	NNS	O	5	SUB	O
O	O	O	592	604	specifically	specifically	B-ADVP	RB	O	5	VMOD	O
O	O	O	605	610	bound	bind	B-VP	VBD	O	0	ROOT	O
O	O	O	611	617	either	either	O	CC	O	18	NMOD	O
O	O	O	618	625	octamer	octamer	B-NP	NN	B-protein	9	NMOD	B-protein
O	O	O	626	639	transcription	transcription	I-NP	NN	I-protein	9	NMOD	I-protein
O	O	O	640	646	factor	factor	I-NP	NN	I-protein	18	NMOD	I-protein
O	O	O	647	649	or	or	O	CC	O	18	NMOD	O
T9	B-Entity	B-Entity	650	657	nuclear	nuclear	B-NP	JJ	B-protein	18	NMOD	B-protein
T9	I-Entity	I-Entity	658	664	factor	factor	I-NP	NN	I-protein	18	NMOD	I-protein
T9	I-Entity	I-Entity	665	666	(	(	O	(	I-protein	18	NMOD	I-protein
T9	I-Entity	I-Entity	666	668	NF	NF	B-NP	NN	I-protein	18	NMOD	I-protein
T9	I-Entity	I-Entity	668	669	)	)	O	)	I-protein	18	NMOD	I-protein
T9	I-Entity	I-Entity	669	670	-	-	B-NP	HYPH	I-protein	18	NMOD	I-protein
T9	I-Entity	I-Entity	670	675	kappa	kappa	I-NP	NN	I-protein	18	NMOD	I-protein
T9	I-Entity	I-Entity	676	677	B	B	I-NP	NN	I-protein	5	OBJ	I-protein
O	O	O	677	678	.	.	O	.	O	5	P	O

O	O	O	679	682	The	The	B-NP	DT	O	3	NMOD	O
T10	B-Entity	B-Entity	683	691	modified	modified	I-NP	JJ	O	3	NMOD	O
T10	I-Entity	I-Entity	692	708	oligonucleotides	oligonucleotide	I-NP	NNS	O	4	SUB	O
O	O	O	709	720	accumulated	accumulate	B-VP	VBN	O	0	ROOT	O
O	O	O	721	723	in	in	B-PP	IN	O	4	VMOD	O
O	O	O	724	729	cells	cell	B-NP	NNS	O	5	PMOD	O
O	O	O	730	734	more	more	B-ADVP	RBR	O	8	AMOD	O
O	O	O	735	746	effectively	effectively	I-ADVP	RB	O	4	VMOD	O
O	O	O	747	751	than	than	B-PP	IN	O	8	AMOD	O
T11	B-Entity	B-Entity	752	760	standard	standard	B-NP	JJ	O	12	NMOD	O
T11	I-Entity	I-Entity	761	763	ds	d	I-NP	NNS	O	12	NMOD	O
T11	I-Entity	I-Entity	764	780	oligonucleotides	oligonucleotide	I-NP	NNS	O	16	NMOD	O
O	O	O	781	784	and	and	O	CC	O	16	NMOD	O
O	O	O	785	794	modulated	modulate	B-NP	VBN	O	16	NMOD	O
O	O	O	795	799	gene	gene	I-NP	NN	O	16	NMOD	O
O	O	O	800	810	expression	expression	I-NP	NN	O	9	PMOD	O
O	O	O	811	813	in	in	B-PP	IN	O	16	NMOD	O
O	O	O	814	815	a	a	B-NP	DT	O	20	NMOD	O
O	O	O	816	824	specific	specific	I-NP	JJ	O	20	NMOD	O
O	O	O	825	831	manner	manner	I-NP	NN	O	17	PMOD	O
O	O	O	831	832	.	.	O	.	O	4	P	O

O	O	O	833	840	Octamer	Octamer	B-NP	NN	B-DNA	4	NMOD	B-DNA
O	O	O	840	841	-	-	I-NP	HYPH	O	4	P	O
O	O	O	841	850	dependent	dependent	I-NP	JJ	O	4	NMOD	O
O	O	O	851	861	activation	activation	I-NP	NN	O	26	SUB	O
O	O	O	862	864	of	of	B-PP	IN	O	4	NMOD	O
O	O	O	865	866	a	a	B-NP	DT	O	8	NMOD	O
O	O	O	867	875	reporter	reporter	I-NP	NN	B-DNA	8	NMOD	B-DNA
O	O	O	876	883	plasmid	plasmid	I-NP	NN	I-DNA	13	NMOD	I-DNA
O	O	O	884	886	or	or	I-NP	CC	O	13	NMOD	O
T12	B-Entity	B-Entity	887	889	NF	NF	I-NP	NN	B-protein	13	NMOD	B-protein
T12	I-Entity	I-Entity	889	890	-	-	O	HYPH	I-protein	13	P	I-protein
T12	I-Entity	I-Entity	890	895	kappa	kappa	B-NP	NN	I-protein	13	NMOD	I-protein
T12	I-Entity	I-Entity	896	897	B	B	I-NP	NN	I-protein	16	NMOD	I-protein
O	O	O	897	898	-	-	B-NP	HYPH	O	16	P	O
O	O	O	898	907	dependent	dependent	I-NP	JJ	O	16	NMOD	O
O	O	O	908	918	activation	activation	I-NP	NN	O	5	PMOD	O
O	O	O	919	921	of	of	B-PP	IN	O	16	NMOD	O
O	O	O	922	925	the	the	B-NP	DT	O	25	NMOD	O
T13	B-Entity	B-Entity	926	931	human	human	I-NP	JJ	B-DNA	25	NMOD	B-DNA
T13	I-Entity	I-Entity	932	948	immunodeficiency	immunodeficiency	I-NP	NN	I-DNA	25	NMOD	I-DNA
T13	I-Entity	I-Entity	949	954	virus	virus	I-NP	NN	I-DNA	25	NMOD	I-DNA
T13	I-Entity	I-Entity	955	956	(	(	O	(	I-DNA	25	NMOD	I-DNA
T13	I-Entity	I-Entity	956	959	HIV	HIV	B-NP	NN	I-DNA	25	NMOD	I-DNA
T13	I-Entity	I-Entity	959	960	)	)	O	)	I-DNA	25	NMOD	I-DNA
T13	I-Entity	I-Entity	961	969	enhancer	enhancer	B-NP	NN	I-DNA	17	PMOD	I-DNA
O	O	O	970	973	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	974	983	inhibited	inhibit	I-VP	VBN	O	26	VC	O
O	O	O	984	988	when	when	B-ADVP	WRB	O	26	VMOD	O
O	O	O	989	992	the	the	B-NP	DT	O	32	NMOD	O
O	O	O	993	1004	appropriate	appropriate	I-NP	JJ	O	32	NMOD	O
T14	B-Entity	B-Entity	1005	1021	phosphorothioate	phosphorothioate	I-NP	NN	O	32	NMOD	O
T14	I-Entity	I-Entity	1022	1037	oligonucleotide	oligonucleotide	I-NP	NN	O	33	SUB	O
O	O	O	1038	1041	was	be	B-VP	VBD	O	28	SBAR	O
O	O	O	1042	1047	added	add	I-VP	VBN	O	33	VC	O
O	O	O	1048	1050	to	to	B-PP	TO	O	34	VMOD	O
O	O	O	1051	1052	a	a	B-NP	DT	O	41	NMOD	O
O	O	O	1053	1064	transiently	transiently	I-NP	RB	B-cell_line	41	NMOD	B-cell_line
O	O	O	1065	1076	transfected	transfecte	I-NP	VBN	I-cell_line	41	NMOD	I-cell_line
O	O	O	1077	1078	B	B	I-NP	NN	I-cell_line	41	NMOD	I-cell_line
O	O	O	1079	1083	cell	cell	I-NP	NN	I-cell_line	41	NMOD	I-cell_line
O	O	O	1084	1088	line	line	I-NP	NN	I-cell_line	35	PMOD	I-cell_line
O	O	O	1088	1089	.	.	O	.	O	26	P	O

O	O	O	1090	1098	Addition	Addition	B-NP	NN	O	15	SUB	O
O	O	O	1099	1101	of	of	B-PP	IN	O	1	NMOD	O
T15,T16	B-Entity,B-Entity	B-Entity,B-Entity	1102	1118	phosphorothioate	phosphorothioate	B-NP	NN	O	4	NMOD	O
T15,T16	I-Entity,I-Entity	I-Entity,I-Entity	1119	1135	oligonucleotides	oligonucleotide	I-NP	NNS	O	2	PMOD	O
T15	I-Entity	I-Entity	1136	1140	that	that	B-NP	WDT	O	4	NMOD	O
T15	I-Entity	I-Entity	1141	1150	contained	contain	B-VP	VBD	O	5	SBAR	O
T15	I-Entity	I-Entity	1151	1154	the	the	B-NP	DT	O	9	NMOD	O
T15,T17	I-Entity,B-Entity	I-Entity,B-Entity	1155	1162	octamer	octamer	I-NP	NN	B-DNA	9	NMOD	B-DNA
T15,T17	I-Entity,I-Entity	I-Entity,I-Entity	1163	1172	consensus	consensus	I-NP	NN	I-DNA	6	OBJ	I-DNA
O	O	O	1173	1175	to	to	B-PP	TO	O	1	NMOD	O
O	O	O	1176	1182	Jurkat	Jurkat	B-NP	NN	B-cell_line	14	NMOD	B-cell_line
O	O	O	1183	1184	T	T	I-NP	NN	I-cell_line	14	NMOD	I-cell_line
O	O	O	1185	1193	leukemia	leukemia	I-NP	NN	I-cell_line	14	NMOD	I-cell_line
O	O	O	1194	1199	cells	cell	I-NP	NNS	I-cell_line	10	PMOD	I-cell_line
O	O	O	1200	1209	inhibited	inhibit	B-VP	VBD	O	0	ROOT	O
T1	B-Protein	B-Protein	1210	1221	interleukin	interleukin	B-NP	NN	B-protein	18	NMOD	B-protein
T1	I-Protein	I-Protein	1221	1222	-	-	O	HYPH	O	18	P	O
T1	I-Protein	I-Protein	1222	1223	2	2	B-NP	CD	O	24	NMOD	O
O	O	O	1224	1225	(	(	O	(	O	23	DEP	O
T2	B-Protein	B-Protein	1225	1227	IL	IL	B-NP	NN	B-protein	23	DEP	B-protein
T2	I-Protein	I-Protein	1227	1228	-	-	O	HYPH	I-protein	20	NMOD	I-protein
T2	I-Protein	I-Protein	1228	1229	2	2	O	CD	I-protein	20	NMOD	I-protein
O	O	O	1229	1230	)	)	O	)	O	18	NMOD	O
O	O	O	1231	1240	secretion	secretion	B-NP	NN	O	15	OBJ	O
O	O	O	1241	1243	to	to	B-PP	TO	O	15	VMOD	O
O	O	O	1244	1245	a	a	B-NP	DT	O	27	NMOD	O
O	O	O	1246	1252	degree	degree	I-NP	NN	O	25	PMOD	O
O	O	O	1253	1260	similar	similar	B-ADJP	JJ	O	27	NMOD	O
O	O	O	1261	1263	to	to	B-PP	TO	O	28	AMOD	O
O	O	O	1264	1268	that	that	B-NP	DT	O	29	PMOD	O
O	O	O	1269	1277	observed	observe	B-VP	VBN	O	30	NMOD	O
O	O	O	1278	1282	with	with	B-PP	IN	O	31	VMOD	O
O	O	O	1283	1284	a	a	B-NP	DT	O	36	NMOD	O
T18	B-Entity	B-Entity	1285	1292	mutated	mutate	I-NP	VBN	B-DNA	36	NMOD	B-DNA
T18	I-Entity	I-Entity	1293	1300	octamer	octamer	I-NP	NN	I-DNA	36	NMOD	I-DNA
T18	I-Entity	I-Entity	1301	1305	site	site	I-NP	NN	I-DNA	32	PMOD	I-DNA
O	O	O	1306	1308	in	in	B-PP	IN	O	36	NMOD	O
O	O	O	1309	1312	the	the	B-NP	DT	O	42	NMOD	O
T3	B-Protein	B-Protein	1313	1315	IL	IL	I-NP	NN	B-DNA	42	NMOD	B-DNA
T3	I-Protein	I-Protein	1315	1316	-	-	I-NP	HYPH	I-DNA	42	NMOD	I-DNA
T3	I-Protein	I-Protein	1316	1317	2	2	I-NP	CD	I-DNA	42	NMOD	I-DNA
T19	B-Entity	B-Entity	1318	1326	enhancer	enhancer	I-NP	NN	I-DNA	37	PMOD	I-DNA
O	O	O	1326	1327	.	.	O	.	O	15	P	O

O	O	O	1328	1331	The	The	B-NP	DT	O	2	NMOD	O
O	O	O	1332	1334	ds	d	I-NP	NNS	O	3	SUB	O
T20	B-Entity	B-Entity	1335	1351	phosphorothioate	phosphorothioate	B-VP	VBP	O	0	ROOT	O
T20	I-Entity	I-Entity	1352	1368	oligonucleotides	oligonucleotide	B-NP	NNS	O	3	OBJ	O
O	O	O	1369	1377	probably	probably	B-ADVP	RB	O	6	VMOD	O
O	O	O	1378	1385	compete	compete	B-VP	VBP	O	3	VMOD	O
O	O	O	1386	1389	for	for	B-PP	IN	O	6	VMOD	O
O	O	O	1390	1397	binding	binding	B-NP	NN	O	7	PMOD	O
O	O	O	1398	1400	of	of	B-PP	IN	O	8	NMOD	O
O	O	O	1401	1409	specific	specific	B-NP	JJ	O	12	NMOD	O
O	O	O	1410	1423	transcription	transcription	I-NP	NN	B-protein	12	NMOD	B-protein
O	O	O	1424	1431	factors	factor	I-NP	NNS	I-protein	9	PMOD	I-protein
O	O	O	1432	1435	and	and	O	CC	O	6	VMOD	O
O	O	O	1436	1439	may	may	B-VP	MD	O	3	VMOD	O
O	O	O	1440	1447	provide	provide	I-VP	VB	O	14	VC	O
O	O	O	1448	1452	anti	anti	B-NP	AFX	O	25	NMOD	O
O	O	O	1452	1453	-	-	I-NP	HYPH	O	25	P	O
O	O	O	1453	1458	viral	viral	B-NP	JJ	O	25	NMOD	O
O	O	O	1458	1459	,	,	I-NP	,	O	25	P	O
O	O	O	1460	1477	immunosuppressive	immunosuppressive	I-NP	JJ	O	25	NMOD	O
O	O	O	1477	1478	,	,	O	,	O	25	P	O
O	O	O	1479	1481	or	or	O	CC	O	25	NMOD	O
O	O	O	1482	1487	other	other	B-NP	JJ	O	24	NMOD	O
O	O	O	1488	1499	therapeutic	therapeutic	I-NP	JJ	O	25	NMOD	O
O	O	O	1500	1507	effects	effect	I-NP	NNS	O	15	OBJ	O
O	O	O	1507	1508	.	.	O	.	O	3	P	O
